BamSEC and AlphaSense Join Forces
Learn More

Esperion Therapeutics Inc.

NASDAQ: ESPR    
Share price (1/7/25): $2.17    
Market cap (1/7/25): $428 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 8-K 120 pages Esperion Therapeutics, Inc. and U.S. Bank Trust Company, National Association, as Trustee Indenture Dated as of December 17, 2024 5.75% Convertible Senior Subordinated Notes Due 2030
12/34/56
EX-4.4
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.2
from 8-K 17 pages Pre-Funded Common Stock Purchase Warrant Esperion Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 18 pages Common Stock Purchase Warrant Esperion Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 17 pages Common Stock Purchase Warrant Esperion Therapeutics, Inc
12/34/56
EX-4.4
from S-3ASR 37 pages Esperion Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [ ] Subordinated Debt Securities
12/34/56
EX-4.4
from S-3 37 pages Esperion Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [ ] Subordinated Debt Securities
12/34/56
EX-4.3
from S-3ASR 35 pages Esperion Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [ ] Senior Debt Securities
12/34/56
EX-4.3
from S-3 35 pages Esperion Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [ ] Senior Debt Securities
12/34/56
EX-4.1
from 8-K 128 pages Esperion Therapeutics, Inc. and U.S. Bank National Association, as Trustee Indenture Dated as of November 16, 2020 4.00% Convertible Senior Subordinated Notes Due 2025
12/34/56
EX-4.4
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.2
from S-3 70 pages Esperion Therapeutics, Inc. to Trustee Indenture Dated as of , 20 Subordinated Debt Securities
12/34/56
EX-4.1
from S-3 65 pages Esperion Therapeutics, Inc. to Trustee Indenture Dated as of , 20 Senior Debt Securities
12/34/56
EX-4.2
from S-3 82 pages Esperion Therapeutics, Inc. to Trustee Indenture Dated as of , 20 Subordinated Debt Securities
12/34/56
EX-4.1
from S-3 66 pages Esperion Therapeutics, Inc. to Trustee Indenture Dated as of , 20 Senior Debt Securities
12/34/56
EX-4.1
from 8-K 11 pages Warrant to Purchase Stock
12/34/56
EX-4.2
from S-3 67 pages Esperion Therapeutics, Inc. to Trustee Indenture Dated as of , 20 Subordinated Debt Securities
12/34/56
EX-4.1
from S-3 65 pages Esperion Therapeutics, Inc. to Trustee Indenture Dated as of , 20 Senior Debt Securities
12/34/56
EX-4.1
from S-1/A ~1 page Indenture or similar
12/34/56
EX-4.6
from S-1 20 pages Hdl Therapeutics, Inc. Registration Rights and Securityholder Agreement Hdl Therapeutics, Inc. Registration Rights and Securityholder Agreement
12/34/56